DK0835126T3 - Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser - Google Patents
Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelserInfo
- Publication number
- DK0835126T3 DK0835126T3 DK96923511T DK96923511T DK0835126T3 DK 0835126 T3 DK0835126 T3 DK 0835126T3 DK 96923511 T DK96923511 T DK 96923511T DK 96923511 T DK96923511 T DK 96923511T DK 0835126 T3 DK0835126 T3 DK 0835126T3
- Authority
- DK
- Denmark
- Prior art keywords
- disorders
- amniotic
- formulations
- inhibition
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- 229940035676 analgesics Drugs 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000002981 neuropathic effect Effects 0.000 title 1
- 230000000750 progressive effect Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Control Of El Displays (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/496,847 US5795864A (en) | 1995-06-27 | 1995-06-27 | Stable omega conopetide formulations |
| US08/613,400 US6054429A (en) | 1996-03-08 | 1996-03-08 | Epidural method of producing analgesia |
| PCT/US1996/011041 WO1997001351A1 (en) | 1995-06-27 | 1996-06-26 | Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0835126T3 true DK0835126T3 (da) | 2003-07-14 |
Family
ID=27052304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96923511T DK0835126T3 (da) | 1995-06-27 | 1996-06-26 | Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser |
| DK03007342T DK1336409T3 (da) | 1995-06-27 | 1996-06-26 | Sammensætninger af formuleringer til fremstilling af analgesimidler og til hæmning af fremadskridende neuropatiske smertelidelser |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03007342T DK1336409T3 (da) | 1995-06-27 | 1996-06-26 | Sammensætninger af formuleringer til fremstilling af analgesimidler og til hæmning af fremadskridende neuropatiske smertelidelser |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP1336409B1 (enExample) |
| JP (1) | JP2838073B2 (enExample) |
| AT (2) | ATE359086T1 (enExample) |
| AU (1) | AU695166B2 (enExample) |
| CA (1) | CA2224795C (enExample) |
| DE (3) | DE69637021T2 (enExample) |
| DK (2) | DK0835126T3 (enExample) |
| ES (2) | ES2194998T3 (enExample) |
| FR (1) | FR05C0027I2 (enExample) |
| LU (1) | LU91181I2 (enExample) |
| NL (1) | NL300201I2 (enExample) |
| PT (2) | PT1336409E (enExample) |
| WO (1) | WO1997001351A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5931809A (en) * | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| CA2319038A1 (en) * | 1998-02-20 | 1999-08-26 | Zeneca Limited | Analgesic peptides from venom of grammostola spatulata and use thereof |
| AUPP627498A0 (en) | 1998-10-02 | 1998-10-22 | University Of Queensland, The | Novel peptides - i |
| EP2412719A1 (en) | 2002-12-02 | 2012-02-01 | Xenome Ltd | Chi-conotoxin peptides |
| WO2004050690A1 (en) | 2002-12-02 | 2004-06-17 | Xenome Ltd | NOVEL χ-CONOTOXIN PEPTIDES (-I) |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP1911763B1 (en) | 2003-01-28 | 2010-08-11 | Ironwood Pharmaceuticals, Inc. | Compositions for the treatment of gastrointestinal disorders |
| CA2540895C (en) | 2003-10-02 | 2016-08-02 | Elan Pharmaceuticals, Inc. | Combinations of ziconotide and opioids for reducing pain |
| GB0410215D0 (en) * | 2004-05-07 | 2004-06-09 | Lescroart Pol | Nerve damage |
| US8188048B2 (en) | 2006-06-23 | 2012-05-29 | Xenome Limited | Combination therapy |
| JP2010509209A (ja) * | 2006-11-04 | 2010-03-25 | エニジェン カンパニー リミテッド | 新規なω−コノトキシン |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2300044A4 (en) * | 2008-05-06 | 2012-04-18 | Relevare Aust Pty Ltd | METHOD AND COMPOSITIONS FOR TREATING PAIN WITH OMEGA CONOTOXINES |
| ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US20100221329A1 (en) | 2008-12-03 | 2010-09-02 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase c agonists and methods of use |
| MX381407B (es) | 2008-12-31 | 2025-03-12 | Ardelyx Inc | Compuestos y métodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrógeno (nhe) en el tratamiento de trastornos asociados con retención de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal. |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| MX366293B (es) | 2012-08-21 | 2019-07-04 | Ardelyx Inc | Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal. |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| HRP20191000T1 (hr) | 2013-04-12 | 2019-09-20 | Ardelyx, Inc. | Spojevi za vezanje nhe3 i metode inhibiranja transporta fosfata |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
| MX2019008171A (es) | 2017-01-09 | 2020-02-05 | Ardelyx Inc | Inhibidores del antiporte mediado por nhe. |
| MX395405B (es) | 2017-01-09 | 2025-03-25 | Ardelyx Inc | Compuestos útiles para tratar trastornos del tracto gastrointestinal. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3926287A1 (de) * | 1989-08-09 | 1991-02-21 | Bernhard Clasbrummel | Medizinische anwendung von omega-conotoxin gvia oder omega-conotoxin gvia-analoga zur sympathikolyse |
| US5051403A (en) * | 1989-11-22 | 1991-09-24 | Neurex Corporation | Method of treating ischemia-related neuronal damage |
| AU3074592A (en) * | 1991-11-12 | 1993-06-15 | Neurex Corporation | Compositions for delayed treatment of ischemia-related neuronal damage |
| WO1993013128A1 (en) * | 1991-12-30 | 1993-07-08 | Neurex Corporation | Methods of producing analgesia and enhancing opiate analgesia |
| JPH06247879A (ja) * | 1993-02-17 | 1994-09-06 | Bristol Myers Squibb Co | デオキシチミジンヌクレオシドを含有する注射用製剤の安定化方法およびその方法によって得られる安定化注射用製剤 |
-
1996
- 1996-06-26 EP EP03007342A patent/EP1336409B1/en not_active Expired - Lifetime
- 1996-06-26 PT PT03007342T patent/PT1336409E/pt unknown
- 1996-06-26 DK DK96923511T patent/DK0835126T3/da active
- 1996-06-26 PT PT96923511T patent/PT835126E/pt unknown
- 1996-06-26 DE DE69637021T patent/DE69637021T2/de not_active Expired - Lifetime
- 1996-06-26 ES ES96923511T patent/ES2194998T3/es not_active Expired - Lifetime
- 1996-06-26 DK DK03007342T patent/DK1336409T3/da active
- 1996-06-26 AT AT03007342T patent/ATE359086T1/de active
- 1996-06-26 DE DE1996627153 patent/DE122005000043I2/de active Active
- 1996-06-26 DE DE69627153T patent/DE69627153T2/de not_active Expired - Lifetime
- 1996-06-26 AU AU64002/96A patent/AU695166B2/en not_active Ceased
- 1996-06-26 WO PCT/US1996/011041 patent/WO1997001351A1/en not_active Ceased
- 1996-06-26 AT AT96923511T patent/ATE235914T1/de active
- 1996-06-26 CA CA002224795A patent/CA2224795C/en not_active Expired - Fee Related
- 1996-06-26 ES ES03007342T patent/ES2283671T3/es not_active Expired - Lifetime
- 1996-06-26 EP EP96923511A patent/EP0835126B1/en not_active Expired - Lifetime
- 1996-06-27 JP JP8188120A patent/JP2838073B2/ja not_active Expired - Fee Related
-
2005
- 2005-06-23 FR FR05C0027C patent/FR05C0027I2/fr active Active
- 2005-07-06 LU LU91181C patent/LU91181I2/fr unknown
- 2005-07-13 NL NL300201C patent/NL300201I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2224795A1 (en) | 1997-01-16 |
| WO1997001351A1 (en) | 1997-01-16 |
| AU695166B2 (en) | 1998-08-06 |
| FR05C0027I2 (enExample) | 2006-12-29 |
| PT835126E (pt) | 2003-07-31 |
| EP0835126B1 (en) | 2003-04-02 |
| FR05C0027I1 (enExample) | 2005-08-12 |
| JP2838073B2 (ja) | 1998-12-16 |
| AU6400296A (en) | 1997-01-30 |
| NL300201I1 (nl) | 2005-09-01 |
| EP0835126A1 (en) | 1998-04-15 |
| HK1058146A1 (en) | 2004-05-07 |
| DE69637021D1 (de) | 2007-05-24 |
| NL300201I2 (nl) | 2006-02-01 |
| ATE235914T1 (de) | 2003-04-15 |
| LU91181I2 (fr) | 2005-09-06 |
| DE122005000043I2 (de) | 2006-08-03 |
| EP1336409B1 (en) | 2007-04-11 |
| CA2224795C (en) | 2001-04-03 |
| DE69627153T2 (de) | 2003-12-04 |
| ES2194998T3 (es) | 2003-12-01 |
| DE69627153D1 (de) | 2003-05-08 |
| JPH09104634A (ja) | 1997-04-22 |
| ES2283671T3 (es) | 2007-11-01 |
| DK1336409T3 (da) | 2007-08-13 |
| EP1336409A1 (en) | 2003-08-20 |
| DE69637021T2 (de) | 2008-01-10 |
| ATE359086T1 (de) | 2007-05-15 |
| DE122005000043I1 (de) | 2006-06-29 |
| PT1336409E (pt) | 2007-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0835126T3 (da) | Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser | |
| NO20053105D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag. | |
| DK1014966T3 (da) | Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser | |
| DK0723435T3 (da) | Oral doseringsform af metoprolol til administration én gang dagligt | |
| GEP20033027B (en) | Use of Substituted Benzopyran Analogs for Treatment of Inflammation | |
| FR2685869B1 (fr) | Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase. | |
| NO971206D0 (no) | Forlenget-frigjöringsformulering | |
| MY115662A (en) | Novel compounds with analgesic effect | |
| BR9407720A (pt) | Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto | |
| AU2308192A (en) | Instrument for registration of the dental bite | |
| FI950947L (fi) | Oraalisesti annettavat farmaseuttiset formulaatiot | |
| ES2194107T3 (es) | Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales. | |
| BR9610983A (pt) | Formas estáveis de administração farmacêuticas contendo paratormônio | |
| HUP9801227A2 (hu) | Monoamin-oxidáz B inhibitorokból álló gyógyászati készítmények és alkalmazásuk | |
| HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| EP0601058A4 (en) | TRANSDERMAL FORMULATIONS FOR PRRAZOSINE ADMINISTRATION. | |
| HUP0000963A2 (hu) | A levobupivakain gyermeksebészeti alkalmazása | |
| EA199700151A1 (ru) | Композиция для чрескожного введения | |
| EP0683668A4 (en) | PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION. | |
| IS5366A (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| LT96093A (en) | The active ingredient of pharmaceutical composition for treating aphtae and stomatitis | |
| FR2732219B1 (fr) | Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes | |
| WO1998031355A3 (en) | Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease |